vs
Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
CB Financial Services, Inc. is the larger business by last-quarter revenue ($13.8M vs $9.2M, roughly 1.5× Foghorn Therapeutics Inc.). On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 19.9%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 1.2%).
CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
CBFV vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $9.2M |
| Net Profit | — | $-21.7M |
| Gross Margin | — | — |
| Operating Margin | 38.1% | -258.2% |
| Net Margin | — | -234.3% |
| Revenue YoY | 19.9% | 223.8% |
| Net Profit YoY | — | -11.1% |
| EPS (diluted) | $0.90 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $9.2M | ||
| Q3 25 | $2.4M | $8.2M | ||
| Q2 25 | $13.5M | $7.6M | ||
| Q1 25 | $12.1M | $6.0M | ||
| Q4 24 | $13.2M | $2.9M | ||
| Q3 24 | $12.7M | $7.8M | ||
| Q2 24 | $12.2M | $6.9M | ||
| Q1 24 | $13.5M | $5.0M |
| Q4 25 | — | $-21.7M | ||
| Q3 25 | $-5.7M | $-15.8M | ||
| Q2 25 | $3.9M | $-17.9M | ||
| Q1 25 | $1.9M | $-18.8M | ||
| Q4 24 | — | $-19.5M | ||
| Q3 24 | $3.2M | $-19.1M | ||
| Q2 24 | $2.6M | $-23.0M | ||
| Q1 24 | $4.2M | $-25.0M |
| Q4 25 | 38.1% | -258.2% | ||
| Q3 25 | -289.8% | -226.9% | ||
| Q2 25 | 35.0% | -279.2% | ||
| Q1 25 | 19.3% | -385.0% | ||
| Q4 24 | 23.1% | -840.5% | ||
| Q3 24 | 31.2% | -305.5% | ||
| Q2 24 | 26.4% | -386.6% | ||
| Q1 24 | 37.9% | -558.3% |
| Q4 25 | — | -234.3% | ||
| Q3 25 | -235.2% | -194.4% | ||
| Q2 25 | 29.3% | -237.3% | ||
| Q1 25 | 15.8% | -316.4% | ||
| Q4 24 | — | -682.9% | ||
| Q3 24 | 25.3% | -244.9% | ||
| Q2 24 | 21.8% | -333.6% | ||
| Q1 24 | 31.1% | -495.4% |
| Q4 25 | $0.90 | $-0.35 | ||
| Q3 25 | $-1.07 | $-0.25 | ||
| Q2 25 | $0.74 | $-0.28 | ||
| Q1 25 | $0.35 | $-0.30 | ||
| Q4 24 | $0.45 | $-0.23 | ||
| Q3 24 | $0.60 | $-0.31 | ||
| Q2 24 | $0.51 | $-0.45 | ||
| Q1 24 | $0.82 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $80.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $157.5M | $-108.5M |
| Total Assets | $1.5B | $198.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $80.9M | ||
| Q3 25 | $55.9M | $89.3M | ||
| Q2 25 | $64.5M | $72.6M | ||
| Q1 25 | $61.3M | $61.0M | ||
| Q4 24 | $49.6M | $55.5M | ||
| Q3 24 | $147.3M | $57.7M | ||
| Q2 24 | $142.6M | $138.9M | ||
| Q1 24 | $73.7M | $79.3M |
| Q4 25 | $157.5M | $-108.5M | ||
| Q3 25 | $152.5M | $-89.7M | ||
| Q2 25 | $148.4M | $-76.7M | ||
| Q1 25 | $148.3M | $-61.7M | ||
| Q4 24 | $147.4M | $-45.5M | ||
| Q3 24 | $149.1M | $-28.3M | ||
| Q2 24 | $142.9M | $-14.3M | ||
| Q1 24 | $141.6M | $-97.5M |
| Q4 25 | $1.5B | $198.1M | ||
| Q3 25 | $1.5B | $205.0M | ||
| Q2 25 | $1.5B | $226.2M | ||
| Q1 25 | $1.5B | $258.7M | ||
| Q4 24 | $1.5B | $284.0M | ||
| Q3 24 | $1.6B | $308.4M | ||
| Q2 24 | $1.6B | $328.6M | ||
| Q1 24 | $1.5B | $255.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $-22.3M |
| Free Cash FlowOCF − Capex | $17.2M | — |
| FCF MarginFCF / Revenue | 124.1% | — |
| Capex IntensityCapex / Revenue | 4.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $-22.3M | ||
| Q3 25 | $4.6M | $-18.9M | ||
| Q2 25 | $4.1M | $-21.0M | ||
| Q1 25 | $4.0M | $-24.0M | ||
| Q4 24 | $6.8M | $-24.5M | ||
| Q3 24 | $3.1M | $-21.0M | ||
| Q2 24 | $-1.2M | $-25.5M | ||
| Q1 24 | $3.3M | $-29.3M |
| Q4 25 | $17.2M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $3.9M | $-21.0M | ||
| Q1 25 | $3.9M | $-24.0M | ||
| Q4 24 | $3.4M | $-25.0M | ||
| Q3 24 | $2.2M | $-21.3M | ||
| Q2 24 | $-2.4M | $-25.6M | ||
| Q1 24 | $2.3M | $-29.4M |
| Q4 25 | 124.1% | — | ||
| Q3 25 | 186.5% | — | ||
| Q2 25 | 28.8% | -278.2% | ||
| Q1 25 | 32.5% | -403.2% | ||
| Q4 24 | 26.0% | -875.3% | ||
| Q3 24 | 17.4% | -273.0% | ||
| Q2 24 | -19.6% | -371.0% | ||
| Q1 24 | 17.0% | -583.1% |
| Q4 25 | 4.7% | 0.0% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 1.9% | 0.3% | ||
| Q1 25 | 0.8% | 0.5% | ||
| Q4 24 | 25.1% | 16.8% | ||
| Q3 24 | 6.7% | 4.0% | ||
| Q2 24 | 10.0% | 0.2% | ||
| Q1 24 | 7.2% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.44× | — | ||
| Q1 24 | 0.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
